Melbourne pathology to use microbiology system
Melbourne Pathology will be the first Australian laboratory to acquire PREVI Isola, based on LBT Innovations MicroStreak technology for automated agar plate streaking in microbiology laboratories.
Melbourne Pathology is a Sonic-owned laboratory providing services to GPs, medical specialists, nursing homes and private hospitals in greater Melbourne and regional Victoria.
LBT Innovations’ CEO and Managing Director, Lusia Guthrie, said, “This technology has the potential to radically change the way infectious diseases laboratories operate. It streamlines laboratory processes and gives superior results for patients. This is a huge step forward and we are thrilled that the system is now being installed in Australian laboratories."
The sale of the first PREVI Isola in Australia triggers a payment of $20,000 by LBT Innovations to Medvet Science Pty Ltd from whom the core technology was licensed.
Flinders works on method to filter nanoplastics from water
Flinders University researchers are working on a method capable of detecting nanoplastics using...
March workshops seek to empower NT flood evacuees
In March, a workshop series will bring together researchers and community members to co-design a...
Colon cancer DNA in blood can guide chemo decisions
A simple blood test could change how doctors decide which patients with colon cancer need...
